Skip to main content
. Author manuscript; available in PMC: 2006 Jun 1.
Published in final edited form as: Arch Ophthalmol. 2005 Nov;123(11):1484–1498. doi: 10.1001/archopht.123.11.1484

Table 7.

Five-Year Rates of Advanced AMD and (for Eyes That Did Not Progress to Advanced AMD) Rates of Progression From Scale Steps 1 to 6 to Step 7 or 8 or to Step 9, for Right and Left Eyes Combined, of Participants Free of Advanced AMD in Both Eyes at Baseline

No. (%)
Step No. at Risk Step 7 or 8 Step 9 NeoAMD CGA N + C
1 2893 11 (0.4) 4 (0.1) 8 (0.3) 0 0
2 899 21 (2.3) 7 (0.8) 5 (0.6) 0 0
3 378 12 (3.2) 3 (0.8) 7 (1.9) 0 0
4 653 90 (13.8) 19 (2.9) 28 (4.3) 3 (0.5) 1 (0.2)
5 380 118 (31.1) 24 (6.3) 20 (5.3) 2 (0.5) 1 (0.3)
6 483 249 (51.6) 40 (8.3) 54 (11.2) 10 (2.1) 3 (0.6)
7 488 NA 93 (19.1) 64 (13.1) 61 (12.5) 12 (2.5)
8 190 NA 37 (19.5) 40 (21.1) 39 (20.5) 11 (5.8)
9 62 NA NA 3 (4.8) 27 (43.5) 3 (4.8)
Total 6426 501 (7.8) 227 (3.5) 229 (3.6) 142 (2.2) 31 (0.5)

Abbreviations: AMD, age-related macular degeneration; CGA, geographic atrophy involving center of macula; NA, not applicable; NeoAMD, neovascular AMD; N + C, NeoAMD + CGA.